As the U.S. pharmaceutical landscape continues to evolve, biosimilars are one of the biggest opportunities for reducing drug costs for employers and consumers. For the past year, CVS Health has been building a strong team of individuals dedicated to increasing access to quality biosimilars for patients. In collaboration with CVS Health’s Cordavis subsidiary, the launch of Hyrimoz is just one example of the culmination of these efforts. I’m proud of this growing Cordavis team and of their commitment to increasing access to critical medications.
Thanks for all your work to keep our world, and those most vulnerable, healthy!
Exciting times!
SR Manager, HRBP
1wAs the U.S. pharmaceutical landscape continues to evolve, biosimilars are one of the biggest opportunities for reducing drug costs for employers and consumers. Way to go Cardavis Colleagues